Immunotherapy for Patients with advanced biliary tract Cancer (BTC) 3-years Update of TOPAZ-1 Study showed Doubling of the Overall Survival Rate with Durvalumab and Chemotherapy Combination

被引：0
|
作者：
Sankawa, Yuri
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer
    Oh, Do-Youn
    He, Aiwu Ruth
    Qin, Shukui
    Chen, Li-Tzong
    Okusaka, Takuji
    Vogel, Arndt
    Kim, Jin Won
    Suksombooncharoen, Thatthan
    Lee, Myung Ah
    Kitano, Masayuki
    Burris, Howard
    Bouattour, Mohamed
    Tanasanvimon, Suebpong
    McNamara, Mairead G.
    Zaucha, Renata
    Avallone, Antonio
    Tan, Benjamin
    Cundom, Juan
    Lee, Choong-kun
    Takahashi, Hidenori
    Ikeda, Masafumi
    Chen, Jen-Shi
    Wang, Julie
    Makowsky, Mallory
    Rokutanda, Nana
    Zotkiewicz, Magdalena
    Kurland, John F.
    Cohen, Gordon
    Valle, Juan W.
    FUTURE ONCOLOGY, 2023, 19 (34) : 2277 - 2289
  • [2] Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1) : updated overall survival from a randomised phase 3 study
    Oh, Do-Youn
    He, Aiwu Ruth
    Bouattour, Mohamed
    Okusaka, Takuji
    Qin, Shukui
    Chen, Li-Tzong
    Kitano, Masayuki
    Lee, Choong-kun
    Kim, Jin Won
    Chen, Ming -Huang
    Suksombooncharoen, Thatthan
    Ikeda, Masafumi
    Lee, Myung Ah
    Chen, Jen-Shi
    Potemski, Piotr
    Burris, Howard A.
    Ostwal, Vikas
    Tanasanvimon, Suebpong
    Morizane, Chigusa
    Zaucha, Renata E.
    Mcnamara, Mairead G.
    Avallone, Antonio
    Cundom, Juan E.
    Breder, Valeriy
    Tan, Benjamin
    Shimizu, Satoshi
    Tougeron, David
    Evesque, Ludovic
    Petrova, Mila
    Zhen, David B.
    Gillmore, Roopinder
    Gupta, Vineet Govinda
    Dayyani, Farshid
    Park, Joon Oh
    Buchschacher Jr, Gary L.
    Rey, Felipe
    Kim, Hyosung
    Wang, Julie
    Morgan, Claire
    Rokutanda, Nana
    Zotkiewicz, Magdalena
    Vogel, Arndt
    Valle, Juan W.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (08): : 694 - 704
  • [3] Regional subgroup analysis of the phase 3 TOPAZ-1 study of durvalumab (D) plus gemcitabine and cisplatin (GC) in advanced biliary tract cancer (BTC).
    Vogel, Arndt
    Chen, Li-Tzong
    He, Aiwu Ruth
    Kim, Jin Won
    Chen, Ming-Huang
    McNamara, Mairead Geraldine
    Shimizu, Satoshi
    Gillmore, Roopinder
    Rey, Felipe
    Kim, Hyosung
    Xiong, Julia
    Makowsky, Mallory
    Rokutanda, Nana
    Cohen, Gordon
    Oh, Do-Youn
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin ( plus GC) in patients (pts) with advanced biliary tract cancer (BTC)
    Oh, D. Y.
    He, A. R.
    Qin, S.
    Chen, L. T.
    Okusaka, T.
    Vogel, A.
    Kim, J. W.
    Suksombooncharoen, T.
    Lee, M. A.
    Kitano, M.
    Burris, H. A.
    Bouattour, M.
    Tanasanvimon, S.
    Zaucha, R. E.
    Avallone, A.
    Cundom, J. E.
    Rokutanda, N.
    Watras, M.
    Cohen, G.
    Valle, J. W.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S565 - S566
  • [5] Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin ( plus GC) in patients (pts) with advanced biliary tract cancer (BTC)
    Oh, D-Y.
    He, A. R.
    Qin, S.
    Chen, L-T.
    Okusaka, T.
    Vogel, A.
    Kim, J. W.
    Lee, T.
    Lee, M. A.
    Kitano, M.
    Burris, H. A.
    Bouattour, M.
    Tanasanvimon, S.
    Zaucha, R. E.
    Avallone, A.
    Cundom, J. E.
    Rokutanda, N.
    Zotkiewicz, M.
    Cohen, G.
    Valle, J. W.
    ANNALS OF ONCOLOGY, 2022, 33 : S1462 - S1463
  • [6] Potentially prognostic factors of overall survival in advanced biliary tract cancer in the randomised phase III TOPAZ-1 study
    He, A. R.
    Bouattour, M.
    Gupta, V. G.
    Evesque, L.
    Zhen, D. B.
    Park, J. O.
    Sookprasert, A.
    Salvatierra, A.
    Vaccaro, G. M.
    Oh, S. C.
    Ostoich, S. A.
    Satoh, T.
    Zotkiewicz, M.
    Rokutanda, N.
    Kim, H.
    Oh, D-Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S220 - S220
  • [7] A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1
    Oh, Do-Youn
    He, Aiwu Ruth
    Qin, Shukui
    Chen, Li-Tzong
    Okusaka, Takuji
    Vogel, Arndt
    Kim, Jin Won
    Suksombooncharoen, Thatthan
    Lee, Myung Ah
    Kitano, Masayuki
    Burris, Howard A., III
    Bouattour, Mohamed
    Tanasanvimon, Suebpong
    Zaucha, Renata
    Avallone, Antonio
    Cundom, Juan
    Rokutanda, Nana
    Xiong, Julia
    Cohen, Gordon
    Valle, Juan W.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [8] Outcomes by disease status in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 study
    Okusaka, T.
    Kitano, M.
    Chen, M.
    Chen, J.
    Ostwal, V.
    McNamara, M.
    Breder, V.
    Petrova, M.
    Buchschacher, G., Jr.
    Rokutanda, N.
    Xiong, J.
    Cohen, G.
    Oh, D.
    ANNALS OF ONCOLOGY, 2022, 33 : S242 - S242
  • [9] Outcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 study
    He, A.
    Valle, J.
    Lee, C.
    Ikeda, M.
    Potemski, P.
    Morizane, C.
    Cundom, J.
    Tougeron, D.
    Dayyani, F.
    Rokutanda, N.
    Xiong, J.
    Cohen, G.
    Oh, D.
    ANNALS OF ONCOLOGY, 2022, 33 : S378 - S378
  • [10] Patient-reported outcomes for the phase 3 TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer.
    Burris, Howard A., III
    Okusaka, Takuji
    Vogel, Arndt
    Lee, Myung Ah
    Takahashi, Hidenori
    Breder, Valeriy Vladimirovich
    Blanc, Jean-Frederic
    Li, Junhe
    Watras, Magdalena
    Xiong, Julia
    Abraham, Jayne
    Patel, Nikunj
    Wang, Julie
    Rokutanda, Nana
    Cohen, Gordon
    Oh, Do-Youn
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345